The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The winning streak looks set to come to an end today, with the ASX200 tipped to take a half a per cent loss.

It was the end of an eight-day rally in the US overnight, with the S&P500 and Nasdaq shedding .2% and the Dow Jones also down about 60 points (.15%).

Volatility picked up as investors sought hints on the size of the now highly-anticipated rate cut next month.

Back home, plenty of FY24 reports are coming in…

One of the first out the gate was Cleanaway Waste Management (ASX:CWY) which posted an annual statutory net profit for FY24 nearly $135 million – or more than 570% – higher than for the previous year.  

Insurer Insurance Australia Group (ASX:IAG) reported profit up 8% to just below $900 million, and, its full year dividend is 80% up on FY23.

Pallets, crates and containers company Brambles (ASX:BXB) also reported profit after tax some 8% higher, and it’s dividend is up 30% on the previous financial year.

The Australian dollar is stronger today – its buying US67.4c.

Gold is up nearly half a per cent to US$2515 an ounce, iron ore is just above US$98 ($98.10) a tonne, brent crude has shed three quarters of a per cent to US$77 a barrel, and, natural gas is just under US$2.20 a gigajoule. ($2.19).

More From The Market Online
Nuclear explosion mushroom cloud concept

Week 47 Wrap: HotCopper users’ most watched; Brent lifts on Putin’s scary letter; RFK dents CSL

Welcome to the end of another week. Let's start with what HotCopper users have been watching…
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Dale Gillham’s weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in th…
Image of eyes in closeup

Scientific conference spotlights PYC’s work on blindness disease treatment

PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat…
Image of four gold necklaces

Sales growth pushes Lovisa’s fortunes (and shares) upwards

Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and…